In previous work, the mRNA expression of HNF4A was significantly decreased in human NASH samples, suggesting a contribution of HNF4A to NAFLD through regulation of the expression of the genes involved in the progression of NAFLD to hepatocellular carcinoma [55]. The gene discussed is HNF4A; the disease is metabolic dysfunction-associated steatohepatitis.